clinical trial · NCT06024642
Study of V117957 in Overactive Bladder Syndrome
Overactive Bladder SyndromeV117957Placebo
brief summary
The purpose of this study is to evaluate the safety, tolerability and efficacy of V117957 in subjects with overactive bladder syndrome, compared to placebo.
started
Jun 30, 2022
primary completion
May 21, 2024
completion
May 21, 2024
last updated
Jun 26, 2025
official title
Multicenter, Randomized, Double-blind Placebo-controlled, Crossover Study to Investigate Effects of V117957 in Female Subjects With Overactive Bladder Syndrome
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol